🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
An international, multicenter, non-interventional, prospective, post-author...
Status
Active Not Recruiting
Location
Sandoz Investigational Site Belgium
Start Date
2023-02-16
Trial ID
NCT05633771
Treatments Being Tested
Biosimilars represent great potential in cost saving and reinvestment oppor...
Status
Unknown
Location
Chu Grenoble Alpes
Start Date
2020-06-19
Trial ID
NCT04422171
To investigate the effect of filgotinib on phenotype, B cell receptor (BCR)...
Status
Unknown
Location
Leiden University Medical Center
Start Date
2022-10
Trial ID
NCT05502731
Treatments Being Tested
BACKGROUND/RATIONALE: Treatment outcomes of patients with inflammatory bow...
Status
Enrolling By Invitation
Location
Universitair Ziekenhuis Gent
Start Date
2021-03-11
Trial ID
NCT04646187
Treatments Being Tested
Crohn's disease (CD) is a condition that causes inflammation (swelling, red...
Status
Recruiting
Location
Phoenix Children's Hospital
Start Date
2023-06-10
Trial ID
NCT05781152
Treatments Being Tested
The rationale for this study is to investigate whether in psoriatic arthrit...
Status
Unknown
Location
Universitätsklinikum Erlangen
Start Date
2020-10-19
Trial ID
NCT04610476
The goal of this clinical trial is to learn whether children and young adul...
Status
Not Yet Recruiting
Location
University of California, Los Angeles
Start Date
2026-09
Trial ID
NCT07699107
Treatments Being Tested
The rationale for this study is to use immune molecule-specific drug treatm...
Status
Completed
Location
Addenbrooks Hopsital
Start Date
2022-11-04
Trial ID
NCT05090124
Treatments Being Tested
Hyrimoz™ was developed as a biosimilar to HumiraTM (INN: adalimumab) and Ze...
Status
Completed
Location
Sandoz Investigational Site
Start Date
2019-06-24
Trial ID
NCT03890445
This was a randomized, parallel-group, open-label, multicenter study in pat...
Status
Completed
Location
Novartis Investigative Site
Start Date
2019-06-04
Trial ID
NCT03906136
Treatments Being Tested